- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Chronic HCV infection: epidemiological and clinical relevance ; volume:12 ; number:2 ; day:12 ; month:11 ; year:2012 ; pages:1-7 ; date:11.2012
BMC infectious diseases ; 12, Heft 2 (12.11.2012), 1-7, 11.2012
- Urheber
-
Zaltron, S.
- Beteiligte Personen und Organisationen
-
Spinetti, A.
Biasi, L.
Baiguera, C.
Castelli, F.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-12-S2-S2
- URN
-
urn:nbn:de:1111-2016050228330
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zaltron, S.
- Spinetti, A.
- Biasi, L.
- Baiguera, C.
- Castelli, F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HCV-specific T cell responses during and after chronic HCV infection
Characterization of NK cell immunity in chronic HCV infection
Heterogeneity of HCV-specific CD8+ T cells during chronic HCV infection and after cessation of chronic antigen stimulation
Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
Characterization of heme oxygenase 1 based therapy options in chronic persistent HCV infection
Managing HCV infection: present and future
HCV-specific T cell responses during and after chronic HCV infection
Characterization of NK cell immunity in chronic HCV infection
Heterogeneity of HCV-specific CD8+ T cells during chronic HCV infection and after cessation of chronic antigen stimulation
Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
Characterization of heme oxygenase 1 based therapy options in chronic persistent HCV infection
Managing HCV infection: present and future
HCV-specific T cell responses during and after chronic HCV infection
Characterization of NK cell immunity in chronic HCV infection
Heterogeneity of HCV-specific CD8+ T cells during chronic HCV infection and after cessation of chronic antigen stimulation
Soluble egg antigen of Schistosoma Haematobiuminduces HCV replication in PBMC from patients with chronic HCV infection
Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection
Reply to "Vitamin D deficiency and HCV chronic infection: What comes first?"
Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment
Characterization of heme oxygenase 1 based therapy options in chronic persistent HCV infection